MYC and colorectal cancer: For example, m6A modification stabilizes and promotes the expression of SOX2 through IGF2BP2-dependent pathways and increases the expression of its downstream targets (CCND1, MYC, and POU5F1), which in turn promotes the occurrence, invasion, and metastasis of colorectal cancer [135].